Mouse Models for Immunotherapy in Hepatocellular Carcinoma

Tekijä Li, Enya, Lin, Li, Chen, Chia-Wei, Ou, Da-Liang
Julkaisussa Cancers (Basel) (2019)

IκB kinases increase Myc protein stability and enhance progression of breast cancer cells

Tekijä Yeh, Pei-Yen, Lu, Yen-Shen, Ou, Da-Liang, Cheng, Ann-Lii
Julkaistu 2011

Simultaneous visualization of the subfemtomolar expression of microRNA and microRNA target gene using HILO microscopy

Tekijä Lin, Yi-Zhen, Ou, Da-Liang, Chang, Hsin-Yuan, Lin, Wei-Yu, Hsu, Chiun, Chang, Po-Ling
Julkaisussa Chem Sci (2017)

Potentiating the Efficacy of Molecular Targeted Therapy for Hepatocellular Carcinoma by Inhibiting the Insulin-Like Growth Factor Pathway

Tekijä Ou, Da-Liang, Lee, Bin-Shyun, Chang, Ya-Chi, Lin, Liang-In, Liou, Jun-Yang, Hsu, Chiun, Cheng, Ann-Lii
Julkaistu 2013

Vertical blockade of the IGFR- PI3K/Akt/mTOR pathway for the treatment of hepatocellular carcinoma: the role of survivin

Tekijä Ou, Da-Liang, Lee, Bin-Shyun, Lin, Liang-In, Liou, Jun-Yang, Liao, Sheng-Chieh, Hsu, Chiun, Cheng, Ann-Lii
Julkaistu 2014

Zebrafish as a disease model for studying human hepatocellular carcinoma

Tekijä Lu, Jeng-Wei, Ho, Yi-Jung, Yang, Yi-Ju, Liao, Heng-An, Ciou, Shih-Ci, Lin, Liang-In, Ou, Da-Liang
Julkaisussa World J Gastroenterol (2015)

Cytarabine-Resistant FLT3-ITD Leukemia Cells are Associated with TP53 Mutation and Multiple Pathway Alterations—Possible Therapeutic Efficacy of Cabozantinib

Tekijä Ko, Ya-Chen, Hu, Chung-Yi, Liu, Zheng-Hau, Tien, Hwei-Fang, Ou, Da-Liang, Chien, Hsiung-Fei, Lin, Liang-In
Julkaisussa Int J Mol Sci (2019)

TARBP2‐mediated destabilization of Nanog overcomes sorafenib resistance in hepatocellular carcinoma

Tekijä Lai, Hui‐Huang, Li, Chih‐Wei, Hong, Chih‐Chen, Sun, Hung‐Yu, Chiu, Ching‐Feng, Ou, Da‐Liang, Chen, Pai‐Sheng
Julkaisussa Mol Oncol (2019)

Growth arrest DNA damage-inducible gene 45 gamma expression as a prognostic and predictive biomarker in hepatocellular carcinoma

Tekijä Ou, Da-Liang, Shyue, Song-Kun, Lin, Liang-In, Feng, Zi-Rui, Liou, Jun-Yang, Fan, Hsiang-Hsuan, Lee, Bin-Shyun, Hsu, Chiun, Cheng, Ann-Lii
Julkaisussa Oncotarget (2015)

KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells

Tekijä Lin, Yu-Lin, Liau, Jau-Yu, Yu, Shan-Chi, Ou, Da-Liang, Lin, Liang-In, Tseng, Li-Hui, Chang, Yih-Leong, Yeh, Kun-Huei, Cheng, Ann-Lii
Julkaistu 2012

Regorafenib enhances antitumor immunity via inhibition of p38 kinase/Creb1/Klf4 axis in tumor-associated macrophages

Tekijä Ou, Da-Liang, Chen, Chia-Wei, Hsu, Chia-Lang, Chung, Chih-Hung, Feng, Zi-Rui, Lee, Bin-Shyun, Cheng, Ann-Lii, Yang, Muh-Hwa, Hsu, Chiun
Julkaisussa J Immunother Cancer (2021)

Development of a PD-L1-Expressing Orthotopic Liver Cancer Model: Implications for Immunotherapy for Hepatocellular Carcinoma

Tekijä Ou, Da-Liang, Lin, Yu-Yang, Hsu, Chia-Lang, Lin, Yin-Yao, Chen, Chia-Wei, Yu, Jhang-Sian, Miaw, Shi-Chuen, Hsu, Ping-Ning, Cheng, Ann-Lii, Hsu, Chiun
Julkaisussa Liver Cancer (2019)